Research and Markets: MediPoint: Bone Grafts and Substitutes - US Analysis and Market Forecasts

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/hc3q3d/medipoint_bone) has announced the addition of the "MediPoint: Bone Grafts and Substitutes - US Analysis and Market Forecasts" report to their offering.

Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the most popular option during bone grafting in the Asia-Pacific (APAC) region and South America.

The majority of the market revenue for BGS is contributed by the US. Medtronic is considered the top player in the US market due to its strength in multiple segments. In the allograft bone space (including both traditional and machined allograft bone segments), Medtronic and MTF were two of the tier one players in 2013. In the BMP/growth factor segment, Medtronic's dominance is widely considered not replicable despite surgeons' dampened enthusiasm about its INFUSE Bone Graft.

Scope

- An overview of BGS, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

- Annualized the US BGS market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.

- Investigation of current and future market competition for BGS

- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.

- Competitor assessment including device approval analysis and device sales forecasts.

- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.

- Analysis of unmet needs within the market and opportunities for future players.

- Technology trends evaluation to assess strength of pipeline.

- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Clinical Outcomes

4 Industry Overview

Competitive Assessment

Unmet Needs

Pipeline Products

Clinical Trials to Watch

Current and Future Players

Market Outlooks

Appendix

List of Tables

List of Figures

Companies Mentioned

Alphatec Spine

AlloSource

Bacterin

Biomet

DePuy Synthes

Exactech

Globus Medical

Integra LifeSciences

Medtronic

NuVasive

Olympus Biotech

Orthofix

RTI Surgical

Stryker

Wright Medical

Zimmer Holdings

For more information visit http://www.researchandmarkets.com/research/hc3q3d/medipoint_bone

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices